Accepted at 3:44 p.m. Feb, 10, 2024 by Cameron
Author: mohannadkh10
Related Note: 1482971607268
Rationale for change

Amboss basically says that the "overall 5-year suvival rate: 10%, and for metastatic CA around 3% 5 year survival and with successful resection goes up to 20%"

I think it's safe to use 10% as a 5 year survival instead of 1 year
Source: AMBOSS - https://next.amboss.com/us/article/3S0Sz2?q=pancreatic+cancer#Z9424d25f102a72f5a7046ce7336ea9f8

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Empty field
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Gastroenterology::07_Pancreas::07_Pancreatic_Adenocarcinoma #PANCE::EOR::Family_med #AK_Step1_v12::#Low/HighYield::5-LowYield #AK_Step1_v12::#FirstAid::09_Gastrointestinal::04_Pathology::53_Pancreatic_adenocarcinoma #AK_Step1_v12::#OME::04_Organ_Systems::03_Gastrointestinal::01_Digestion_&_Absorption::10_Pancreas_Pathology #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Endocrinology::Pancreatic_adenocarcinoma #AK_Step2_v12::#SketchyIM::11_Hepatobiliary::06_Pancreatic_Disease::02_Pancreatic_Cancer #AK_Step1_v12::#Physeo::11_Pathology::06_Gastrointestinal_Pathology::10_Pancreas #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_GI::GI_Pathology #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb::Pancreatic_adenoca #PANCE::GI::neoplasms #AK_Step1_v12::#B&B::10_GI::03_Clinical_Gastroenterology::11_Chronic_Pancreatitis_&_Pancreatic_Cancer #AK_Step1_v12::#Pathoma::11_Exocrine,Pancreas,Gallbladder,&Liver::01_Exocrine_Pancreas #AK_Step2_v12::#B&B::06_GI::03_Biliary_Tree_and_Pancreas::03_Pancreatic_Cancer #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::03_Gastrointestinal::01_Digestion_&_Absorption::10_Pancreas_Pathology #AK_Step1_v12::^Systems::GI::pathology #PANCE::EOR::Surgery